Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MUCOMYST W/ ISOPROTERENOL | Mead Johnson Nutrition | N-017366 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ISOPROTERENOL HYDROCHLORIDE | 3M | N-010375 DISCN | 1982-01-01 | 1 products |
NORISODRINE AEROTROL | Abbott Biotherapeutics | N-016814 DISCN | 1982-01-01 | 1 products |
ISUPREL | Bausch Health Companies | N-010515 DISCN | 1982-01-01 | 1 products, RLD |
VAPO-ISO | Fisons | N-016813 DISCN | 1982-01-01 | 1 products |
AEROLONE | Eli Lilly | N-007245 DISCN | 1982-01-01 | 1 products |
ISUPREL | Sanofi | N-006327 DISCN | 1982-01-01 | 2 products |
ISUPREL | Sanofi | N-006328 DISCN | 1982-01-01 | 2 products |
ISUPREL | Sanofi | N-011178 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
isoproterenol | ANDA | 2024-01-14 |
isoproterenol hydrochloride | ANDA | 2024-01-02 |
Code | Description |
---|---|
J7657 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7658 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
J7659 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7660 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | 1 | — | 1 | 6 | 8 |
Vasodilation | D014664 | — | — | 1 | — | — | 1 | — | 2 |
Vasoconstriction | D014661 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | — | 2 | 1 | — | — | 2 |
Kidney calculi | D007669 | EFO_0004253 | N20 | — | 2 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lipoma | D008067 | — | D17.9 | 1 | 1 | — | — | — | 1 |
Ureteroscopy | D018666 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | 1 | — | — | — | 1 | 2 |
Orthostatic intolerance | D054971 | — | — | 1 | — | — | — | 1 | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | 2 | — | — | — | — | 2 |
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Orthostatic hypotension | D007024 | — | I95.1 | 1 | — | — | — | — | 1 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | — | 1 |
Pure autonomic failure | D054970 | — | — | 1 | — | — | — | — | 1 |
Shy-drager syndrome | D012791 | EFO_1001050 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | — | — | 4 | 4 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | — | — | 2 | 2 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 2 | 2 |
Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | — | — | — | 2 | 2 |
Sudden death cardiac | D016757 | EFO_0004278 | — | — | — | — | — | 2 | 2 |
Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | — | — | — | — | 2 | 2 |
Hypotension | D007022 | EFO_0005251 | I95 | — | — | — | — | 1 | 1 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
Tachycardia | D013610 | HP_0001649 | R00.0 | — | — | — | — | 1 | 1 |
Primary dysautonomias | D054969 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Isoproterenol |
INN | isoprenaline |
Description | Isoprenaline is a secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders. It has a role as a sympathomimetic agent, a beta-adrenergic agonist, a bronchodilator agent and a cardiotonic drug. It is a member of catechols, a secondary amino compound and a secondary alcohol. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)NCC(O)c1ccc(O)c(O)c1 |
PDB | — |
CAS-ID | 7683-59-2 |
RxCUI | — |
ChEMBL ID | CHEMBL434 |
ChEBI ID | 64317 |
PubChem CID | 3779 |
DrugBank | DB01064 |
UNII ID | L628TT009W (ChemIDplus, GSRS) |